NCT03341559

Brief Summary

This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers. The investigators will perform longitudinal imaging (for 12 months) in two cohorts of subjects

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 14, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

March 20, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2020

Completed
Last Updated

March 24, 2020

Status Verified

March 1, 2020

Enrollment Period

1.8 years

First QC Date

November 6, 2017

Last Update Submit

March 23, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perfusion in lower extremities

    SFDI data outputs

    12-month

Study Arms (2)

With Existing Diabetic Ulcers

Current DFU

Device: Spatial Frequency Domain Imaging (SFDI)

Diabetic Ulcers in remission

DFU in remission

Device: Spatial Frequency Domain Imaging (SFDI)

Interventions

Observational study to measure perfusion in lower extremities for prediction of both healing and formation of diabetic foot ulcers using Reflect RS

Also known as: Reflect RS
Diabetic Ulcers in remissionWith Existing Diabetic Ulcers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Male or female patients at University of Southern California diagnosed with a Diabetic Foot Ulcer

You may qualify if:

  • I. Will be followed up in clinic on monthly basis for the next 12 months per standard of care II. Belong to one of the two target groups
  • Subjects with an existing diabetic foot ulcer
  • Subjects determined "at risk" for an ulcer

You may not qualify if:

  • History of heart failure
  • Rheumatoid arthritis
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keck Medical Center of USC

Los Angeles, California, 90033, United States

Location

Related Publications (1)

  • Murphy GA, Singh-Moon RP, Mazhar A, Cuccia DJ, Rowe VL, Armstrong DG. Quantifying dermal microcirculatory changes of neuropathic and neuroischemic diabetic foot ulcers using spatial frequency domain imaging: a shade of things to come? BMJ Open Diabetes Res Care. 2020 Nov;8(2):e001815. doi: 10.1136/bmjdrc-2020-001815.

MeSH Terms

Conditions

Diabetic Foot

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery and Director, Southwestern Academic Limb Salvage Alliance (SALSA)

Study Record Dates

First Submitted

November 6, 2017

First Posted

November 14, 2017

Study Start

March 20, 2018

Primary Completion

December 31, 2019

Study Completion

February 13, 2020

Last Updated

March 24, 2020

Record last verified: 2020-03

Locations